These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 1208224)

  • 1. The action of L-dopa in rats with the raphe nuclei lesions.
    Maj J; Przewlocka B
    Pol J Pharmacol Pharm; 1975 Oct; 27(Suppl):151-4. PubMed ID: 1208224
    [No Abstract]   [Full Text] [Related]  

  • 2. The role of brain 5-hydroxytryptamine in the central action of L-DOPA.
    Maj J; Pawlowski L; Sarnek J
    Adv Biochem Psychopharmacol; 1974; 10():253-6. PubMed ID: 4846541
    [No Abstract]   [Full Text] [Related]  

  • 3. Central D-fenfluramine action.
    Mogilnicka E; Maj J; Pawlowski L; Garncarczyk L
    Pol J Pharmacol Pharm; 1975 Oct; 27(Suppl):161-6. PubMed ID: 1082127
    [No Abstract]   [Full Text] [Related]  

  • 4. [The influence of 1-DOPA on emotional responses and serotonin metabolism in the rat brain].
    Allikmets LKh; Zharkovskiĭ AM
    Biull Eksp Biol Med; 1976 Feb; 81(2):134-7. PubMed ID: 1084170
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The hypothermic effect of L-dopa in the rat.
    Maj J; Pawlowksi L
    Life Sci; 1973 Jul; 13(2):141-9. PubMed ID: 4270866
    [No Abstract]   [Full Text] [Related]  

  • 6. Ethanol, levodopa and inhibitors of extracerebral aromatic L-amino acid decarboxylase: a drug-drug interaction study.
    Messiha FS
    Proc West Pharmacol Soc; 1977; 20():327-31. PubMed ID: 896840
    [No Abstract]   [Full Text] [Related]  

  • 7. Dopaminergic functional supersensitivity: effects of chronic L-dopa and carbidopa treatment in an animal model of Parkinson's disease.
    Hossain MA; Weiner N
    J Pharmacol Exp Ther; 1993 Dec; 267(3):1105-11. PubMed ID: 8263772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serotonergic activation after 2-week intrastriatal infusion of L-dopa and slow recovery of circling in rats with unilateral nigral lesions.
    Kääriäinen TM; García-Horsman JA; Piltonen M; Huotari M; Männistö PT
    Basic Clin Pharmacol Toxicol; 2008 Mar; 102(3):300-7. PubMed ID: 17973898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of the effects of decarboxylase inhibitors on L-dopa-induced circling behavior and the conversion of dopa to dopamine in the brain.
    Goodale DB; Moore KE
    Life Sci; 1976 Sep; 19(5):701-6. PubMed ID: 957902
    [No Abstract]   [Full Text] [Related]  

  • 10. Age-dependent depressor effect of L-dopa in dogs with inhibition of extracerebral dopa decarboxylase.
    Wilke WL
    Pediatr Res; 1983 Nov; 17(11):924-5. PubMed ID: 6359046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of the adrenergic system in the action of L-DOPA on brain serotonin.
    Algeri S; Cerletti C
    Adv Biochem Psychopharmacol; 1974; 10():257-9. PubMed ID: 4846542
    [No Abstract]   [Full Text] [Related]  

  • 12. Habenular modulation of raphe indoleamine metabolism.
    Speciale SG; Neckers LM; Wyatt RJ
    Life Sci; 1980 Dec; 27(24):2367-72. PubMed ID: 6163060
    [No Abstract]   [Full Text] [Related]  

  • 13. [Mechanisms of regulating monoamine oxidase activity in different brain regions].
    Petrenko SV; Balakleevskiĭ AI
    Vopr Med Khim; 1980; 26(2):264-70. PubMed ID: 7456358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of L-dopa alone and with benserazide on the spontaneous activity of striatal neurones in normal and 6-hydroxydopamine-lesioned rats.
    Chang WY; Webster RA
    Br J Pharmacol; 1997 May; 121(2):331-7. PubMed ID: 9154345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pressor effects of electrical stimulation of the dorsal and median raphe nuclei in anesthetized rats.
    Kuhn DM; Wolf WA; Lovenberg W
    J Pharmacol Exp Ther; 1980 Aug; 214(2):403-9. PubMed ID: 6104727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of L-dihydroxyphenylalanine on rat behavior and on catecholamine metabolism of the brain in rats with different degrees of emotional-behavioral reactivity].
    Bondarenko NA; Miroshnichenko II; Kudrin VS; Bondarenko NA
    Biull Eksp Biol Med; 1988 Aug; 106(8):168-70. PubMed ID: 3416051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. L-dopa-induced desensitization depends on 5-hydroxytryptamine imbalance in hemiparkinsonian rats.
    Kääriäinen TM; García-Horsman JA; Piltonen M; Männistö PT
    Neuroreport; 2009 Feb; 20(3):313-8. PubMed ID: 19188858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Central action of L-DOPA in blood pressure regulation and effect on catecholamine content in the frog, Xenopus laevis.
    Henning M; Johansson P
    Comp Biochem Physiol C Comp Pharmacol; 1981; 70(1):117-21. PubMed ID: 6117402
    [No Abstract]   [Full Text] [Related]  

  • 19. The parkinsonian neurotoxin 1-methyl-4-phenylpyridinium (MPP(+)) mediates release of l-3,4-dihydroxyphenylalanine (l-DOPA) and inhibition of l-DOPA decarboxylase in the rat striatum: a microdialysis study.
    Foster SB; Wrona MZ; Han J; Dryhurst G
    Chem Res Toxicol; 2003 Oct; 16(10):1372-84. PubMed ID: 14565778
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of L-dopa on pupillary diameter in mice.
    Korczyn AD; Keren O
    Experientia; 1982 Apr; 38(4):481-2. PubMed ID: 7084415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.